Daily happenings?., page-210

Hey mate did you go through the presentation that was presented or did you validate your perspective from share price?
the whole point of the initial phase of the collaboration was to see if they were able to produce a non viral product which was achieved at a 40% discount to cost of LVV. also they reported they work able to achieve cryopreservation in which the cells were frozen then unfrozen and then armed and it was achieved. now in regards to TF going forward it was stated in the presentation under next step 'clinical scale development on dynacellect and xenon' which are TF products so going forward most likely they are involved and a new deal is currently getting negotiated which explains the silence we are experiencing.

And honestly if you expecting in management to do a full monty with the TF name in market announcements while a deal most likely getting negotiated is bad buisness practice. Be wary of management who over sells there apples not the ones that are protecting them.